TCRX TSCAN THERAPEUTICS INC
2026Q1 · CUSIP 89854M101 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
59
Δ holders QoQ
-1
Breadth percentile
Top 66%
Whale holders
36
Δ whales
+1
Inst. holding value
$662M
New positions
11
Closed positions
12
Price momentum (1Q)
+2.6%
Put / Call
0/0
Breadth history (34 quarters)
Past Lit Events & Aftermath 1 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2024Q2 | Top 19% | -16.0% | -63.8% |
Options Sentiment
Put holders
0
QoQ: 0
Call holders
0
QoQ: 0
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-0.96
EPS YoY
—
Revenue (TTM)
$0.0B
Revenue YoY
+106.7%
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)